WHO ICTRP trial

Prophylactic combined chemotherapy for patients with cholangiocarcinoma after…

EUCTR2012-005078-70-DE · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2012-005078-70-DE
Public title Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.
Scientific title Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) A randomized, multidisciplinary, multinational AIO/DGAV/DGVS phase III trial.
Primary sponsor University Medical Center Hamburg-Eppendorf
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Netherlands;Austria;Denmark;United Kingdom;Italy;Australia;Germany
Conditions Cholangiocarcinoma and gallbladder carcinoma MedDRA version: 20.0 Level: LLT Classification code 10017620 Term: Gallbladder carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA…
Interventions Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Capecitabine Other descriptive name: CAPECITABINE Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal Concentration number: 1250- Pharmaceutical Form…
Registration date Aug 22, 2013
Target size 781
Secondary IDs ACTICCA-1
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations